HRP20090488T1 - Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate - Google Patents

Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Info

Publication number
HRP20090488T1
HRP20090488T1 HR20090488T HRP20090488T HRP20090488T1 HR P20090488 T1 HRP20090488 T1 HR P20090488T1 HR 20090488 T HR20090488 T HR 20090488T HR P20090488 T HRP20090488 T HR P20090488T HR P20090488 T1 HRP20090488 T1 HR P20090488T1
Authority
HR
Croatia
Prior art keywords
amino
isobutyl
hydroxypropylcarbamate
hexahydrofuro
aminophenyl
Prior art date
Application number
HR20090488T
Other languages
English (en)
Croatian (hr)
Inventor
Martha Felix Goyvaerts Nicolaas
Tom Bert Paul Wigerinck Piet
Burghard Zinser Hartmut
M. Ebert Birgit
Original Assignee
Tibotec Pharmaceuticals Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=34740665&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=HRP20090488(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tibotec Pharmaceuticals Ltd. filed Critical Tibotec Pharmaceuticals Ltd.
Publication of HRP20090488T1 publication Critical patent/HRP20090488T1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Furan Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
HR20090488T 2003-12-23 2009-09-15 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate HRP20090488T1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP03104949 2003-12-23
US56818304P 2004-05-04 2004-05-04
PCT/EP2004/053692 WO2005063770A1 (en) 2003-12-23 2004-12-23 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Publications (1)

Publication Number Publication Date
HRP20090488T1 true HRP20090488T1 (en) 2009-10-31

Family

ID=34740665

Family Applications (1)

Application Number Title Priority Date Filing Date
HR20090488T HRP20090488T1 (en) 2003-12-23 2009-09-15 Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate

Country Status (21)

Country Link
EP (1) EP1725566B1 (pt)
KR (1) KR101192859B1 (pt)
CN (1) CN1898248B (pt)
AT (1) ATE433982T1 (pt)
AU (1) AU2004309122B2 (pt)
BR (1) BRPI0417272B8 (pt)
CA (1) CA2549460C (pt)
CY (1) CY1109379T1 (pt)
DE (1) DE602004021640D1 (pt)
DK (1) DK1725566T3 (pt)
ES (1) ES2328701T3 (pt)
HR (1) HRP20090488T1 (pt)
IL (1) IL174960A (pt)
MX (1) MXPA06007211A (pt)
NO (1) NO337636B1 (pt)
PL (1) PL1725566T3 (pt)
PT (1) PT1725566E (pt)
RU (1) RU2376308C2 (pt)
SI (1) SI1725566T1 (pt)
WO (1) WO2005063770A1 (pt)
ZA (1) ZA200605163B (pt)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR058238A1 (es) 2005-11-28 2008-01-23 Tibotec Pharm Ltd Compuestos y derivados de aminofenilsulfonamida sustituida como inhibidores de proteasa del vih
ATE497499T1 (de) * 2006-11-09 2011-02-15 Tibotec Pharm Ltd Verfahren zur herstellung von hexahydrofuroä2,3- büfuran-3-ol
JP2010525029A (ja) 2007-04-27 2010-07-22 テイボテク・フアーマシユーチカルズ・リミテツド Ｎ−イソブチル−ｎ−（２−ヒドロキシ−３−アミノ−４−フェニルブチル）−ｐ−ニトロベンゼンスルホニルアミド誘導体の製造方法
WO2009055006A1 (en) * 2007-10-26 2009-04-30 Concert Pharmaceuticals, Inc. Deuterated darunavir
US8592487B2 (en) 2007-10-26 2013-11-26 Concert Pharmaceuticals, Inc. Deuterated darunavir
TWI482775B (zh) * 2008-09-01 2015-05-01 Tibotec Pharm Ltd 用於製備（３ｒ，３ａｓ，６ａｒ）－六氫呋喃并〔２，３－ｂ〕呋喃－３－基（１ｓ，２ｒ）－３－〔〔（４－胺基苯基）磺醯基〕（異丁基）胺基〕－１－苯甲基－２－羥基丙基胺基甲酸酯之方法
US8921415B2 (en) 2009-01-29 2014-12-30 Mapi Pharma Ltd. Polymorphs of darunavir
BRPI1010546B8 (pt) * 2009-05-13 2022-08-23 Meiji Seika Pharma Co Ltd processo para produzir composto, método para isolar e purificar cristais de solvato do composto, e, uso do composto
EP2477992B1 (en) 2009-09-17 2016-12-14 Mylan Laboratories Limited Processes for the preparation of darunavir and the amorphous form thereof
KR20120123077A (ko) 2010-01-05 2012-11-07 씨아이피엘에이 엘티디. 다루나비르 다형체 및 그의 제조 방법
AU2011210349A1 (en) 2010-01-28 2012-07-05 Mapi Pharma Limited Process for the preparation of darunavir and darunavir intermediates
CN102584844B (zh) * 2011-01-11 2016-04-13 浙江九洲药业股份有限公司 一种达芦那韦晶型及其制备方法
EP3795572B1 (en) * 2012-07-24 2023-11-15 Laurus Labs Limited Darunavir propionate solvate
CN103893178B (zh) * 2014-03-19 2016-06-01 中山大学 苯-磺酰胺类化合物在制备抗hiv-1病毒药物中的应用
US20160075643A1 (en) * 2014-09-16 2016-03-17 Zcl Chemicals Limited Novel process to prepare intermediates of hiv-protease inhibitors thereof
WO2016207907A1 (en) * 2015-06-25 2016-12-29 Msn Laboratories Private Limited Process for the preparation of [(1 s,2r)-3-[[(4-aminophenyl)sulfonyl] (2-methylpropyl)amino]-2-hydroxy-1 -(phenylmethyl)propyl]-carbamic acid (3r,3as,6ar)hexahydro furo[2,3-b]furan-3-yl ester and its amorphous form
US10407438B2 (en) 2016-10-27 2019-09-10 Gilead Sciences, Inc. Crystalline forms of darunavir
HUE053006T2 (hu) 2016-11-17 2021-06-28 Janssen Sciences Ireland Unlimited Co Egyszerûsített eljárás darunavir elõállítására
CN118026896A (zh) * 2020-12-30 2024-05-14 上海飞腾医药科技有限公司 抗hiv类药物中间体晶体的生长方法和所得晶体
CN113896658A (zh) * 2021-09-24 2022-01-07 上药康丽（常州）药业有限公司 一种利用微通道反应器合成地瑞那韦中间体的方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6143747A (en) 1995-01-20 2000-11-07 G. D. Searle & Co. Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors
CA2186483A1 (en) 1995-02-03 1996-08-08 Akira Nishiyama Processes for producing .alpha.-halo ketones, .alpha.-halohydrins and epoxides
US5756533A (en) 1995-03-10 1998-05-26 G.D. Searle & Co. Amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US6150556A (en) 1995-03-10 2000-11-21 G. D. Dearle & Co. Bis-amino acid hydroxyethylamino sulfonamide retroviral protease inhibitors
US5705500A (en) 1995-03-10 1998-01-06 G.D. Searle & Co. Sulfonylalkanoylamino hydroxyethylamino sulfonamide retroviral protease inhibitors
CZ297676B6 (cs) 1995-03-10 2007-03-07 G. D. Searle & Co. Deriváty hydroxyethylaminosulfonamidu jako inhibitory retrovirové proteázy, farmaceutická kompozice
ATE334121T1 (de) 1999-01-29 2006-08-15 Kaneka Corp Verfahren zur herstellung von threo-1,2-epoxy-3- amino-4-phenylbutan-derivaten
KR20020046948A (ko) 2000-12-12 2002-06-21 에가시라 구니오 에폭사이드 결정의 제조방법
ATE429431T1 (de) 2001-05-11 2009-05-15 Tibotec Pharm Ltd 2-amino-benzoxazol-suphonamide als breitspektrum- hiv-protease-inhibitoren
CA2472133A1 (en) * 2001-12-28 2003-07-17 Ajinomoto Co., Inc. Process for producing crystal of benzenesulfonamide derivative, and novel crystal of intermediate therefor and process for producing the same

Also Published As

Publication number Publication date
CA2549460C (en) 2014-08-05
EP1725566B1 (en) 2009-06-17
AU2004309122B2 (en) 2011-07-21
IL174960A0 (en) 2006-08-20
RU2376308C2 (ru) 2009-12-20
CY1109379T1 (el) 2014-07-02
ATE433982T1 (de) 2009-07-15
MXPA06007211A (es) 2006-08-18
PT1725566E (pt) 2009-09-16
BRPI0417272B1 (pt) 2020-08-18
ES2328701T3 (es) 2009-11-17
DE602004021640D1 (de) 2009-07-30
IL174960A (en) 2011-06-30
CN1898248B (zh) 2011-08-17
BRPI0417272B8 (pt) 2021-05-25
KR101192859B1 (ko) 2012-10-19
AU2004309122A1 (en) 2005-07-14
DK1725566T3 (da) 2009-10-05
PL1725566T3 (pl) 2009-11-30
NO337636B1 (no) 2016-05-23
CA2549460A1 (en) 2005-07-14
ZA200605163B (en) 2007-12-27
NO20063401L (no) 2006-07-21
RU2006126670A (ru) 2008-01-27
KR20060123740A (ko) 2006-12-04
CN1898248A (zh) 2007-01-17
WO2005063770A1 (en) 2005-07-14
EP1725566A1 (en) 2006-11-29
SI1725566T1 (sl) 2009-12-31
BRPI0417272A (pt) 2007-03-27

Similar Documents

Publication Publication Date Title
IL174960A0 (en) Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
UA85567C2 (en) Process for the preparation of (3r,3as,6ar)-hexahydrofuro [2,3-b] furan-3-yl (1s,2r)-3-[[(4-aminophenyl) sulfonyl] (isobutyl) amino]-1-benzyl-2-hydroxypropylcarbamate
CY1119311T1 (el) Ψευδο-πολυμορφικες μορφες καταστολεα πρωτεασης hiv
HRP20040320B1 (hr) POSTUPAK ZA PRIPRAVU HEKSAHIDRO-FURO[2,3-b]FURAN-3-OLA
WO2006076415A3 (en) Exo- and diastereo- selective syntheses of himbacine analogs
MX2009004957A (es) Metodos para la preparacion de hexahidrofuro[2,3-b]furan-3-ol.
ATE516933T1 (de) Rasierergriff und herstellungsverfahren dafür
WO2005103614A3 (en) Dark-banded vial for use with level
NO20064977L (no) Fremgangsmater for fremstilling av (3R,3aS,6aR)-heksahydro-furo[2,3-b]furan-3-ol
WO2006102535A3 (en) Sulfonyl containing compounds as cysteine protease inhibitors
BRPI0408417A (pt) métodos para a produção de um resìduo de gla purificado contendo serina protease, para a purificação de um resìduo de gla contendo serina protease e para estabilização de um resìduo de gla contendo serina protease, e, composição
BR112012009956A2 (pt) um novo processo para a preparação de darunavir e etanolato darunavir de tamanho de partícula.
HUP0402253A2 (hu) Eljárás N-[3-(3-ciano-pirazolo[1,5-a]pirimidin-7-il)-fenil]-N-etil-acetamid (zaleplon) tisztítására és új kristályformáinak előállítására, valamint az új kristályformákat tartalmazó gyógyszerkészítmények
EA200600563A1 (ru) Способ получения рензаприда и его промежуточных соединений
NO20061951L (no) Fremgangsmater for fremstillingen av benzoksazol-sulfonamid-forbindelser og intermediater derav
BRPI0411652A (pt) processo para a preparação de derivados de espirobenzoazepina substituìdos não-peptìdicos
HUP0400525A2 (hu) Eljárás benzol-dimetanol vegyület előállítására
TW200716948A (en) Micro gyroscope
WO2004043911A3 (en) N-cycloalkylglycines as hiv protease inhibitors
FR2883215B1 (fr) Procede d'usinage d'une face de lentille optalmique prismee au centre
EP1262308A3 (fr) Procédé de fabrication d'un composant optique, moule pour la mise en oeuvre de ce procédé et composant optique obtenu par ce procédé
MY140929A (en) Container structure for lots or chips
RS20050727A (en) Process for the production of imidazopyridin-8-ones